Timothy Waje | Epidemiology of viral diseases | Best Academic Researcher Award

Published on by Global Diseases Research

Mr. Timothy Waje | Epidemiology of viral diseases | Best Academic Researcher Award 

Ph.D.Researcher at Abubakar Tafawa Balewa University Bauchi ,Nigeria

Timothy Waje is a dedicated Nigerian professional with a strong commitment to health education, disease control, and research. He blends leadership, strategic planning, and organizational skills in both academic and field environments. Known for his work in neglected tropical diseases, his career spans public health, microbiology, and institutional leadership. Timothy has excelled in managing complex projects under pressure, fostering collaborations, and achieving measurable results in challenging environments across northern Nigeria. His multidisciplinary approach combines scientific research, policy engagement, and grassroots mobilization. With a natural ability to train and lead, he continuously drives health improvements through capacity-building initiatives and innovative solutions. His familiarity with Nigeria’s diverse regional contexts enhances his effectiveness in community engagement and program implementation. In every role, Timothy demonstrates integrity, dedication, and a passion for public service, making him an influential figure in the health and research sectors.

Professional Profile

Scopus

Education

Timothy Waje has pursued a progressive academic path rooted in microbiology and public health. His foundational studies equipped him with deep knowledge in applied microbiology, research methodology, and epidemiology. Through advanced degrees, he developed expertise in medical microbiology and expanded his understanding of infectious disease control, biostatistics, and public health systems. His academic journey is marked by continuous learning and critical thinking, supported by hands-on training in laboratory sciences and data analysis. Waje’s education reflects a clear alignment with his professional focus, as he explored both theoretical and practical aspects of disease transmission, diagnostics, and community-based health strategies. He has also acquired strong competencies in research design, data interpretation, and scientific communication. These qualifications have not only enhanced his academic credentials but also strengthened his leadership in public health interventions, particularly in northern Nigeria. His commitment to education continues to shape his impact as a trainer, researcher, and mentor in the field.

Experience

Timothy Waje brings a wealth of experience across the fields of public health, microbiology, education, and banking. As a provost, he has overseen administrative and academic functions, trained staff, led institutional governance, and taught core subjects in microbiology and disease control. In public health, he has served as a consultant and field expert on multiple neglected tropical diseases programs, successfully conducting surveys, monitoring treatments, and leading community mobilization. His roles have involved supervising data collection, analyzing survey outcomes, and managing implementation logistics. He has also played critical roles in organizing training sessions, facilitating capacity development, and interacting with government and health agencies. Before transitioning into health leadership, Timothy worked in the banking sector, where he excelled in customer service, compliance, operations, and financial management. Across sectors, his ability to lead, organize, and meet deliverables under pressure has distinguished his career. He adapts easily, solves problems strategically, and mentors others effectively in various roles..

Research Focus

Timothy Waje’s research is grounded in medical microbiology, infectious diseases, and epidemiology, with a special focus on public health concerns in northern Nigeria. His work addresses key health challenges such as cytomegalovirus, lymphatic filariasis, hepatitis viruses, malaria, and Campylobacter infections. Through reviews, clinical studies, and laboratory-based investigations, he examines pathogen prevalence, molecular patterns, genetic diversity, and drug resistance. His research combines both quantitative and qualitative methodologies, often informed by real-world public health interventions. Waje contributes to understanding the spread, diagnosis, and control of diseases that affect vulnerable populations. His investigations aim to inform evidence-based decision-making, improve diagnostics, and support targeted interventions in community settings. He is especially interested in diseases with socioeconomic impacts, focusing on prevention, early detection, and sustainable health education. Waje collaborates with academic, governmental, and international organizations, and is committed to sharing knowledge that advances both science and the practical management of infectious diseases.

Publication Top Notes

Title: Occurrence of Cytomegalovirus among Pregnant Antenatal Women within Bauchi Metropolis, Nigeria

Journal: Clinical Epidemiology and Global Health

Summary:
This study investigates the presence and prevalence of cytomegalovirus (CMV) infection among pregnant women attending antenatal clinics in Bauchi, Nigeria. The research focuses on understanding the epidemiological patterns and potential health implications of CMV infections during pregnancy. Utilizing serological testing methods, the study evaluates CMV exposure levels in a representative sample of pregnant women. The findings contribute to public health awareness regarding maternal CMV infection and stress the need for routine screening in antenatal care settings to reduce potential risks to maternal and fetal health.

Conclusion

Timothy Waje stands out as a versatile professional with a rare combination of academic rigor, field experience, and organizational leadership. His journey reflects a commitment to service, whether through education, scientific research, or health program implementation. In every role, he promotes teamwork, quality delivery, and continuous learning. Waje’s work contributes meaningfully to disease control, institutional development, and capacity building in underserved areas. His interdisciplinary expertise and regional familiarity position him to address complex health challenges with culturally sensitive and evidence-based strategies. Beyond technical skills, his strong ethical foundation, communication abilities, and leadership qualities inspire those he works with. As he continues to advance in research and academic pursuits, his impact is felt across public health, education, and community engagement landscapes. Timothy Waje exemplifies the qualities of a dedicated scholar, capable administrator, and transformative health advocate who consistently strives for excellence, collaboration, and the betterment of society through knowledge and service.

Sajida Nawaz | Nanofibers | Best Researcher Award

Published on by Global Diseases Research

Dr. Sajida Nawaz | Nanofibers | Best Researcher Award

Doctoral at UET, lahore ,Pakistan

Sajida Nawaz is a dedicated physicist and emerging researcher in the field of nanotechnology and biomedical materials. With a background rooted in applied and theoretical physics, she brings strong interdisciplinary insight into the development of innovative nanomaterials for medical and environmental applications. Her work bridges physics, materials science, and biomedical engineering, with a focus on sustainable and biocompatible solutions. She has contributed to multiple collaborative research projects and has represented her work through international conferences and poster presentations. Sajida is highly regarded for her commitment to scientific excellence, detailed experimentation, and hands-on proficiency in advanced characterization techniques. As a visiting scholar, she has extended her academic reach internationally, exploring new methodologies and forming global collaborations. Her drive to address real-world challenges through nanoscience places her at the forefront of applied research, where she continues to grow as a promising scientist contributing to innovative solutions in healthcare and ecological sustainability.

Professional Profile

Google scholar | Scopus

Education

Sajida Nawaz has pursued a structured and in-depth academic path grounded in physics and nanoscience. She began with a foundational degree in physics, where she developed strong analytical and problem-solving skills. Her academic progression continued through postgraduate studies in applied physics, deepening her understanding of material behavior and experimental methods. Furthering her academic journey, she is now engaged in advanced doctoral research with a focus on nanotechnology and biomedical applications. Her academic training has equipped her with a robust understanding of physical principles, along with specialized skills in nanoparticle synthesis, laser-material interaction, and surface morphology. Sajida’s academic work includes the successful completion of dissertations and theses centered on the physicochemical properties of nanomaterials and the impact of irradiation on polymers. Her education blends theoretical learning with practical lab expertise, which has enabled her to contribute meaningfully to scientific research, publications, and collaborations in both national and international academic environments.

Experience 

Sajida Nawaz has gained extensive research and academic experience through a combination of institutional affiliations and international collaborations. She has worked in advanced laboratories focused on material science and nanotechnology, where she developed expertise in techniques such as UV-Vis spectrophotometry, FTIR, XRD, TGA, FESEM, and TEM. Her experience spans both academic and applied research, including the synthesis and characterization of nanomaterials for medical and ecological applications. She has presented her work at scientific workshops, international conferences, and research competitions. As a visiting research scholar at a prominent center for nanotechnology, she expanded her technical capabilities and built global academic networks. Sajida has also co-authored several peer-reviewed articles in reputed journals, demonstrating her ability to contribute meaningfully to interdisciplinary scientific discussions. Her hands-on experience with high-end instrumentation and collaborative projects reflects her capability to work in diverse research settings while contributing original ideas and experimental precision to complex scientific challenges.

Research Focus 

Sajida Nawaz’s research focuses on the intersection of nanotechnology, biomedical engineering, and material science. Her work involves the synthesis and application of biocompatible nanoparticles and nanofibers, particularly for drug delivery and vector control. She specializes in electrospinning and electrospraying techniques to produce functional nanomaterials, often integrating essential oils and chitosan to develop eco-friendly acaricides. Her research also explores laser-matter interaction and polymer surface morphology for industrial and healthcare purposes. Sajida employs a variety of advanced tools, including FESEM, UV-Vis spectrophotometry, XRD, FTIR, and TGA to characterize materials and evaluate their therapeutic and structural properties. She is particularly interested in creating sustainable and effective solutions for disease prevention using nanomedicine and bioassays. Her investigations extend to both theoretical modeling and practical applications, positioning her work at the frontier of global scientific needs. Through collaborative international research, she continues to contribute to advancements in medical nanotechnology and environmental health solutions.

Publication Top Notes

Title: Synthesis, Characterization, and Biocompatibility of Pure and Doped Magnetite Nanoparticles for Magnetic Hyperthermia in Cancer Treatment
Authors: JU Hassan, S Shahzadi, F Waheed, S Nawaz, R Sharif, S Riaz, D Ban
Journal: Applied Physics A
Summary: This research focuses on the preparation and analysis of magnetite nanoparticles, both pure and doped, for use in magnetic hyperthermia cancer therapy. The study evaluates their structural, magnetic, and biocompatibility characteristics, suggesting their promise as safe and effective agents for non-invasive cancer treatment.

Title: Biocontrol Potential of Nano-Encapsulated Essential Oil Crosslinked with Chitosan Nanoparticles Against Tick-Borne Diseases
Authors: S Nawaz, S Shamaila, M Oneeb, JU Hassan, S Ahmad, S Ramakarshina, et al.
Journal: Colloids and Surfaces A: Physicochemical and Engineering Aspects
Summary: This paper investigates the antimicrobial and pesticidal efficacy of essential oils nano-encapsulated with chitosan for controlling ticks. The formulation exhibited enhanced stability and biocontrol properties, offering a potential eco-friendly solution to tick-borne disease management.

Title: ITSM Applications Within Selected Logistics and Transport
Authors: MN Tariq Niamat, Waqar Azeem, Saira Imtiaz, Sajida Nawaz, Kainat Ilyas
Journal: Pakistan Journal of Scientific Research (PJOSR)
Summary: This study assesses the implementation of IT Service Management (ITSM) systems in logistics and transport operations. It discusses how ITSM enhances workflow, reduces operational downtime, and improves service delivery, thereby contributing to digital transformation in supply chains.

Title: AEOF Nano-Encapsulated
Journal: Journal of Population Therapeutics & Clinical Pharmacology
Summary: This article explores the pharmacological potential of nano-encapsulated AEOF compounds. The study emphasizes improved bioavailability, controlled release, and therapeutic targeting, highlighting implications for enhanced drug delivery and patient outcomes in clinical treatments.

Conclusion

Sajida Nawaz exemplifies a new generation of interdisciplinary researchers committed to addressing global health and environmental challenges through science and innovation. With strong academic foundations and hands-on expertise in nanotechnology, she merges theoretical knowledge with real-world applications. Her active participation in collaborative research, both nationally and internationally, reflects her dedication to learning and contributing to global scientific progress. Sajida’s research not only enhances academic understanding but also holds tangible promise for improving lives, particularly in the areas of disease control and sustainable biomedical solutions. Her continued pursuit of innovation through international exposure and scientific inquiry underlines her role as a proactive and forward-thinking scholar. As she advances her doctoral studies and expands her publication record, Sajida remains committed to building bridges across disciplines and borders. Her trajectory signals a career marked by purpose, precision, and potential, making her a valuable contributor to the evolving landscape of nanoscience and applied physics.

Moses Adriko | Schistosomiasis | Best Researcher Award

Published on by Global Diseases Research

Dr. Moses Adriko | Schistosomiasis | Best Researcher Award

Senior Entomologist at Ministry of Health, National Malaria Elimination Division, Uganda

Moses Adriko is a distinguished Senior Entomologist with the Ministry of Health in Uganda, recognized for his expertise in medical entomology, parasitology, and public health leadership. With an academic role as a public health research fellow and reader at Nkumba University, he bridges policy, practice, and academia. Adriko plays a pivotal role in coordinating integrated vector management strategies, especially in controlling malaria vectors and other disease-causing agents. His national and international collaborations have positioned him as a key contributor to the fight against neglected tropical diseases. A respected voice in policy development, he is involved in various global expert committees, including those under the World Health Organization. His contributions extend to environmental health, disease surveillance, and community health systems. Through his leadership, Moses Adriko continues to influence strategic decisions aimed at improving health outcomes across Uganda and beyond.

Professional Profiles

Orcid | Scopus

Education 

Moses Adriko holds a robust academic foundation spanning medical entomology, public health, business administration, and leadership. His doctoral research at Nkumba University investigates fascioliasis within a One Health framework, merging human, animal, and environmental health perspectives. He has completed advanced degrees in public health and business administration from Nexus International University, gaining cross-disciplinary expertise in health policy and management. His formal training includes a bachelor’s degree in science from Makerere University and a diploma in medical entomology and parasitology. Beyond degree programs, Adriko has engaged in continuous professional development through prestigious short courses and certificates offered by institutions in Switzerland, Egypt, Kenya, Sudan, and Zambia. These cover advanced epidemiology, parasitology, disease eradication strategies, research design, and ethical conduct in public health. His educational background has been instrumental in equipping him with the technical and strategic capabilities required for leading complex disease control programs both nationally and globally.

Experience 

Moses Adriko has extensive professional experience in disease control, vector management, and health systems strengthening. As a Senior Entomologist with the Ministry of Health, he is tasked with planning, coordinating, and implementing integrated strategies for vector-borne disease prevention. He has served as a program officer for national bilharzia and worm control initiatives and contributed to externally funded projects like ASCEND. Adriko’s work spans both field and administrative roles, including technical training, stakeholder engagement, and policy execution. In addition to his governmental duties, he has held academic positions, lecturing in medical entomology and parasitology at the Uganda Institute of Allied Health and Management Sciences. He has served on ethics review committees, ensuring compliance in research protocols related to public health. His leadership and hands-on engagement in disease surveillance, community mobilization, and health promotion initiatives have solidified his reputation as a reliable authority in tropical medicine and integrated vector control in Uganda.

Awards and Honors

Moses Adriko has received multiple recognitions for his contributions to tropical disease control and public health research. He has been awarded numerous travel fellowships to attend global workshops and conferences focused on neglected tropical diseases, water infrastructure, and disease eradication strategies. These include events hosted in South Africa, Ethiopia, Tanzania, Senegal, the United Arab Emirates, Kenya, and Zambia. His participation in these prestigious forums reflects his role as both a contributor and thought leader in the field. He has also been recognized for his involvement in advancing community-based health programs and promoting integrated approaches to disease prevention. In addition to conference-based honors, Adriko has been invited to contribute to high-level policy dialogues and project planning sessions organized by international agencies. His consistent engagement with global partners underscores his dedication to translating scientific knowledge into action. These accolades affirm his influence in shaping strategies for disease elimination and health system innovation.

Research Focus

Moses Adriko’s research centers on neglected tropical diseases, with particular emphasis on vector ecology, disease transmission, and integrated control strategies. His current work explores the molecular epidemiology of fascioliasis using a One Health approach, examining the interconnected health of humans, animals, and ecosystems. He has contributed to projects funded by global bodies, including the European Union and international philanthropic organizations, to investigate persistent schistosomiasis infections, praziquantel efficacy, and diagnostic innovation in low-resource settings. Adriko’s research seeks to bridge gaps between clinical, environmental, and policy domains by designing interventions that are scalable, cost-effective, and community-centered. His multidisciplinary collaborations have produced insights into vector biology, drug resistance, and effective surveillance systems. A prolific contributor to peer-reviewed journals, he is also an active manuscript reviewer for leading journals on tropical diseases. His scientific contributions aim to inform national programs and global strategies for eliminating parasitic diseases in sub-Saharan Africa.

Publication Top Notes

Title: Associations between helminth infection status and the composition and concentration of fecal bile acids in school-age children in Uganda
Journal: Scientific Reports
Summary: This study explores how helminth infections influence bile acid profiles in fecal samples from Ugandan children, revealing potential biomarkers of infection and intestinal health.

Title: Meta-analysis and systematic review of the prevalence and risk factors of animal fascioliasis in Eastern and Southern Africa
Summary: A comprehensive meta-analysis identifying the geographic spread, prevalence, and risk determinants of animal fascioliasis to guide veterinary health policy in Eastern and Southern Africa.

Title: Safety and efficacy of praziquantel 40 mg/kg versus 80 mg/kg in preschool-aged children with intestinal schistosomiasis in Uganda: a 2×2 factorial, double-blind, placebo-controlled, phase 2 randomised trial
Journal: Lancet Global Health
Summary: This clinical trial evaluates whether higher dosing of praziquantel is both safe and more effective for preschool-aged children with schistosomiasis, using a rigorous 2×2 factorial trial design.

Title: School-aged Schistosoma mansoni infection levels after long-term programmatic control show failure to meet control programme targets and evidence of a persistent hotspot: evaluation of the FibroScHot trial baseline data
Journal: PLOS Neglected Tropical Diseases
Summary: Baseline data from the FibroScHot trial shows persistent high infection levels of Schistosoma mansoni in some Ugandan areas, suggesting current control efforts are inadequate and hotspots remain.

Title: Development of a latex microsphere-based lateral flow immunoassay for the diagnosis of schistosomiasis japonica
Journal: PLOS Neglected Tropical Diseases
Summary: Researchers developed a novel lateral flow diagnostic tool using latex microspheres to enhance sensitivity and rapid detection of Schistosoma japonicum infections in endemic areas.

Conclusion

Moses Adriko’s professional journey reflects a sustained commitment to combating neglected tropical diseases through science, policy, and community engagement. With a rare blend of technical expertise, academic rigor, and leadership acumen, he has influenced public health interventions at both grassroots and strategic levels. His integrated approach to vector management, grounded in empirical research and field application, continues to drive innovations in disease surveillance and control. Through his academic work, mentorship, and participation in international health committees, Adriko contributes to building resilient health systems that prioritize equity and sustainability. His work is characterized by interdisciplinary collaboration, a deep understanding of disease ecology, and the ability to mobilize diverse stakeholders. As global health challenges evolve, he remains a vital contributor to shaping responsive and evidence-based interventions. His legacy is not only in the policies he has shaped or the programs he has led but also in the lives improved through his dedication to public health.

 

Daouda SAMA | Public Health | Best Researcher Award

Published on by Global Diseases Research

Dr. Daouda SAMA | Public Health | Best Researcher Award

Adjunct Professor at University of Lomé ,Togo

Dr. Daouda Sama is an Adjunct Professor at the Department of Earth Sciences, University of Lomé, Togo. Specializing in environmental geochemistry, his work focuses on pollutant dispersion, health risk assessments, and sustainable coastal management. He has significantly contributed to West African environmental science by modeling industrial emissions and their ecological and human health impacts. His research incorporates advanced tools like AERMOD and Delft3D, bridging scientific understanding and practical application. Dr. Sama has led or contributed to over 40 consultancy projects, guiding environmental impact assessments for major industrial and government clients across West Africa. His academic contributions include 8 peer-reviewed articles in international journals, and he serves as a certified peer reviewer. Actively collaborating with local and international partners, he plays a pivotal role in projects addressing marine pollution, groundwater quality, and regulatory compliance. His work is shaping environmental policy and enhancing ecosystem resilience in developing regions.

Professional Profiles

Scopus | Orcid

Education 

Dr. Daouda Sama has pursued an academically rich path rooted in earth and environmental sciences. He earned his Bachelor’s degree in Geology, followed by a Master’s degree in Hydrology and Hydrogeology from the University of Lomé. He later completed his Ph.D. in Systemic Geochemistry and Multimodal Modeling from the same institution. His doctoral research focused on integrating pollutant dispersion modeling with geochemical assessments to evaluate the health risks of industrial emissions and water contamination. Throughout his studies, he demonstrated a strong interdisciplinary approach, merging geological sciences with public health and environmental policy. His academic journey has been guided by prominent mentors, particularly Prof. Kissao Gnandi, under whose leadership he developed innovative frameworks for environmental monitoring and adaptive quality standards. His educational background has provided a solid foundation for his dual roles in academia and consultancy, allowing him to contribute to both research and applied environmental management.

Experience 

Dr. Daouda Sama brings extensive professional experience from academia, consultancy, and field-based research. As an Adjunct Professor at the University of Lomé, he has taught both undergraduate and graduate courses in earth sciences and has led significant research on geochemistry and pollution assessment. Beyond academia, he has participated in numerous consultancy projects addressing environmental impact assessment, pollution monitoring, geospatial mapping, and water resource management. His clients span national and international institutions, including GIZ, the World Bank, and industrial entities like Dangote and Contour Global. He has worked on projects involving mining waste, coastal pollution, and aquifer contamination across Togo, Benin, Niger, and Congo. His technical roles have included lead analyst, hydrogeologist, and geospatial expert. He is skilled in AAS, spectrophotometry, and modeling software such as Delft3D and AERMOD. His work has directly contributed to policy frameworks, regulatory compliance, and sustainable environmental management in West Africa.

Research Focus 

Dr. Sama’s research centers on environmental geochemistry and its implications for public health and ecosystem resilience. He specializes in modeling the dispersion of pollutants from industrial sources using advanced tools such as AERMOD and Delft3D, enabling receptor-specific risk evaluations near vulnerable sites like schools and clinics. His studies assess the geochemical behavior of mining waste and the bioavailability of contaminants in aquatic systems, particularly along the Gulf of Guinea. He is currently advancing adaptive frameworks for air and water quality that are contextually suited for West African environments. His projects range from modeling the hydrodynamic effects of phosphate discharge to tracking metal pollution in fish and agricultural products. Dr. Sama’s interdisciplinary work integrates geochemistry, public health, and environmental policy, offering practical solutions for pollution mitigation and sustainable development. His research directly supports national and regional efforts to monitor environmental risks, promote regulatory compliance, and protect both ecosystems and communities.

Publication Top Notes

Title: Toxic Trajectories: Modeling Heavy Metal-Laden Phosphate Dust Dispersion and Multi-Receptor Health Risks Near Kpémé’s Industrial Zone

Journal: Results in Engineering

Summary:
This study presents an environmental modeling approach to trace the dispersion of phosphate dust contaminated with heavy metals from industrial activities in Kpémé, Togo. Using advanced atmospheric and geographic modeling tools, the research evaluates how toxic particles travel and affect various environmental and human receptors. The findings reveal elevated risk zones, highlighting vulnerable populations and ecosystems exposed to chronic contamination. The work contributes to industrial pollution management and public health risk assessment by offering a spatially explicit framework for multi-receptor analysis.

Conclusion 

Dr. Daouda Sama exemplifies the synergy of research, teaching, and field-based environmental consultancy. Through a decade of academic and professional contributions, he has established himself as a leader in environmental geochemistry in West Africa. His innovative methods for pollutant dispersion and health risk modeling have shaped environmental policies and regulatory practices in Togo and beyond. As an educator, he fosters critical scientific thinking and environmental responsibility among students. As a consultant, he has provided actionable insights to major stakeholders in industry, government, and international organizations. His scholarly publications and peer review activities reflect his commitment to scientific excellence. Looking ahead, Dr. Sama aims to deepen regional collaborations, expand his geochemical modeling research, and advocate for sustainable industrial practices grounded in data-driven environmental science. His work continues to bridge scientific knowledge and public policy, contributing to a healthier, more resilient future for West African communities and ecosystems.

Giuliano Langella | Soil and Plant Systems | Best Researcher Award

Published on by Global Diseases Research

Assoc. Prof. Dr. Giuliano Langella | Soil and Plant Systems | Best Researcher Award 

Professor of Pedo-informatics at University of Naples Federico II, Italy

Dr. Giuliano Langella is an Italian Associate Professor in Pedology at the Department of Agriculture, Università degli Studi di Napoli Federico II. Born in Torre del Greco, he has built a distinguished career in soil science, particularly in digital soil mapping, geospatial statistics, and pedo-environmental modeling. With a foundation in agricultural sciences and extensive research experience, Dr. Langella combines academic, scientific, and entrepreneurial roles. He is the founder of GeoProc Service, an innovative start-up focused on geospatial solutions for agriculture and environmental monitoring. Over the years, he has collaborated with multiple national and international institutions, including the University of Sydney and BOKU University, and contributed to EU-funded projects. His interdisciplinary teaching and mentoring reflect a commitment to advancing both theory and application in soil and environmental sciences. Passionate about sustainability, precision agriculture, and digital innovation, Dr. Langella continues to influence policy, research, and education in his field.

Professional Profiles

Scopus | Orcid

Education 

Dr. Giuliano Langella holds a Master’s Degree in Agricultural Sciences from the Università degli Studi di Napoli Federico II, completed  with a thesis on olive tree zonation. He earned a PhD in Applied Pedology in 2008, defending a dissertation on digital soil mapping and spatial analysis of environmental features. He is a licensed professional agronomist and a registered technical consultant at the Torre Annunziata Court in Naples.He joined the Agronomist Association of Naples. His academic background integrates traditional soil science with modern geospatial techniques, preparing him for a career that bridges scientific research and applied environmental analysis. Through both his formal education and military service with the 7th Cremona Regiment of Field Heavy Artillery, he developed a strong foundation in discipline and public service. His educational path reflects a focus on environmental sustainability, soil classification, and spatial data analysis, enabling him to contribute meaningfully to the field of pedology.

Experience 

Dr. Giuliano Langella’s professional journey spans academia, research, and entrepreneurship. He currently serves as an Associate Professor in Pedology at the Università degli Studi di Napoli Federico II. Prior to this, he held positions as a tenure-track and non-tenured Assistant Professor in the same department. He also worked as a postdoctoral researcher at the National Research Council (CNR), focusing on statistical modeling of soil and environmental properties and the development of geospatial decision support systems. Parallel to his academic roles, he founded GeoProc Service, an innovative start-up offering advanced geospatial tools for agricultural and environmental decision-making. He has led or participated in international research projects and spent time as a visiting researcher at the University of Sydney and BOKU University. Dr. Langella’s experience showcases his ability to integrate technical innovation with scientific rigor, contributing to sustainable land management and digital transformation in soil science.

Awards and Honors 

Dr. Giuliano Langella has received notable recognition for his scientific contributions in soil and environmental sciences. In , he was co-recipient of the Best Poster Prize at the 14th International Conference on the Biogeochemistry of Trace Elements (ICOBTE) held in Zurich, Switzerland. The award, presented by Division VI – Chemistry and the Environment of the International Union of Pure and Applied Chemistry (IUPAC), recognized his collaborative work on the use of portable XRF analyzers and laboratory techniques to monitor heavy metal contamination in polluted sites. That same year, Dr. Langella was also awarded Best Poster at the XIV AISSA Conference at the Università degli Studi del Molise for his work on “Soil Monitor,” a web-based platform addressing land take and soil sealing issues. These honors reflect his commitment to applied research, innovation in digital soil solutions, and contributions to the environmental monitoring and land management community at both national and international levels.

Research Focus 

Dr. Giuliano Langella’s research centers on digital soil mapping, geospatial statistics, and decision support systems for environmental and agricultural applications. He specializes in modeling soil and hydrological properties across spatial and temporal scales, integrating data from remote sensing, GIS, and field-based observations. His work includes the development of digital applications like WeatherProg, which delivers high-resolution climatic data to support phytopathological modeling. A significant portion of his research explores how digital technologies can optimize land use, monitor soil health, and guide sustainable agricultural practices. He has contributed to EU research initiatives such as the LIFE+ and H2020 LandSupport projects, emphasizing soil sealing, land degradation, and precision farming. His international collaborations further explore 3D soil mapping, AI-assisted land cover classification, and agroecosystem monitoring. Dr. Langella’s interdisciplinary approach bridges agronomy, computer science, and environmental policy, making his research vital for addressing challenges in food security, climate adaptation, and ecosystem management.

Publication Top Notes

Title: Enhancing agricultural meteorology: Qualified data production through an interoperable cyber–physical system
Journal: Computers and Electronics in Agriculture
Summary:
This study presents a cyber–physical system (CPS) framework to improve data reliability and interoperability in agricultural meteorology. By integrating physical sensors and digital infrastructures, the system ensures qualified data production for precision farming, enabling better forecasting, crop management, and sustainable agricultural practices.

Title: Intelligent pest control: AI-driven solutions for sustainable agroecosystems through remote surveillance and descriptive modelling
Summary:
This paper explores the use of artificial intelligence and remote sensing to monitor pest dynamics in real time. It introduces an AI-based decision-support system that utilizes surveillance data and descriptive modelling to promote sustainable pest control in agroecosystems.

Title: A smart soil framework law proposal from Italy: Bridging the gap between policy and implementation
Journal: Soil Security 
Summary:
The article proposes a legislative framework to govern soil health in Italy, incorporating smart agriculture principles. It emphasizes integrating scientific insights into policymaking and developing legal mechanisms to ensure effective on-ground implementation of soil protection strategies.

Title: Integrated, multiscale forensic soil science applied to an unsolved murder case in Italy
Journal: European Journal of Soil Science 
Summary:
This forensic investigation uses multiscale soil analysis to aid a cold-case criminal investigation in Italy. The study demonstrates the application of soil science—from field sampling to lab analysis—to provide critical evidence in forensic contexts, underlining the role of soil in crime solving.

Title: A web-based operational tool for the identification of best practices in European agricultural systems
Summary:
This publication introduces a digital platform designed to support sustainable farming in Europe. The tool collects and analyzes data from diverse agricultural practices across regions to identify and recommend best-performing techniques, thereby enhancing decision-making for farmers and policymakers.

Conclusion 

Dr. Giuliano Langella represents a dynamic force in modern pedology, merging scientific depth with technological innovation. His multidisciplinary expertise—spanning soil science, GIS, remote sensing, and artificial intelligence—positions him as a leader in environmental modeling and sustainable land use. Through academic teaching, industry partnerships, and international research, he contributes solutions to pressing issues like land degradation, climate change, and agricultural efficiency. As a professor, advisor, and entrepreneur, Dr. Langella nurtures future scientists while actively developing tools that make research actionable in real-world settings. His commitment to knowledge transfer is evident through his involvement in start-up innovation, international collaborations, and policy-relevant research. With a solid foundation in traditional agronomic sciences and a forward-looking vision for digital agriculture, Dr. Langella’s career reflects both continuity and transformation in environmental sciences. His work not only advances academic understanding but also provides practical frameworks to support sustainable development and climate resilience at local and global levels.

Sadiq Azam | Clinical Microbiology | Best Researcher Award

Published on by Global Diseases Research

Assoc. Prof. Dr. Sadiq Azam | Clinical Microbiology | Best Researcher Award

Associate Professor at University of Peshawsar, Pakistan

Dr. Sadiq Azam is an accomplished Associate Professor at the University of Peshawar, specializing in microbiology and biotechnology. With over a decade of academic and research experience, he has significantly contributed to understanding antibiotic resistance in pathogenic bacteria and the antimicrobial properties of medicinal plants. Dr. Azam began his academic career at Bacha Khan University and soon joined the University of Peshawar, where he has progressed through various academic ranks. His research includes several completed projects funded by the Higher Education Commission (HEC) and the Directorate of Science and Technology (DoST), focusing on bacteriological profiling, phytochemical analysis, and molecular characterization of drug-resistant pathogens. A certified supervisor, he has mentored numerous M.Phil, PhD, and undergraduate students. He is an active member of academic boards across various institutions and plays a vital role in curriculum development, examination coordination, and teaching innovation. Dr. Azam is fluent in English, Urdu, and Pashto.

Professional Profiles

Scopus

Education 

Dr. Sadiq Azam earned his PhD in Biotechnology from the University of Peshawar, where he had also completed his Bachelor’s in Biotechnology. Prior to his university education, he studied pre-medical sciences at Nisar Shaheed Degree College, Resalpur. His academic journey began with a foundation in science at Government High School, Swabi. Throughout his education, he focused on understanding biological systems and laboratory methodologies, which laid the groundwork for his later research in antimicrobial resistance, pathogenic microorganisms, and medicinal plant compounds. His doctoral work, supported by a prestigious HEC Indigenous Scholarship, marked the beginning of a research career centered on the intersection of microbiology, molecular biology, and pharmacognosy. The academic rigor and scientific training received throughout his education have shaped his multifaceted expertise in clinical microbiology and applied biotechnology. His educational foundation continues to support his teaching, research supervision, and grant-funded investigations in Pakistan’s higher education and health sectors.

Experience 

Dr. Azam’s professional journey began in 2011 as Assistant Professor at Bacha Khan University, Charsadda. He joined the University of Peshawar, where he advanced from Lecturer to Assistant Professor and now serves as an Associate Professor in the Centre for Biotechnology and Microbiology. With over 13 years of teaching and research experience, he has been involved in undergraduate and postgraduate education, thesis supervision, and lab-based training. Beyond teaching, he has led and collaborated on national research projects focused on phytochemical screening and antibiotic resistance. Dr. Azam has played active administrative roles, including BS program coordination and examination management. He is also a member of several Boards of Studies across universities in Khyber Pakhtunkhwa, contributing to academic planning and quality assurance. His career highlights a balance of academic instruction, impactful research, institutional service, and mentorship in the fields of microbiology, biotechnology, and infectious disease research.

Awards and Honors 

Dr. Sadiq Azam was awarded the prestigious HEC Indigenous Scholarship for his M.Phil to PhD studies, recognizing his academic excellence and potential in scientific research. This scholarship provided vital support for his doctoral work in biotechnology at the University of Peshawar and laid the foundation for a research career focused on combating antimicrobial resistance and exploring plant-based therapeutic alternatives. In addition to academic funding, Dr. Azam has successfully secured competitive research grants from Pakistan’s Higher Education Commission (HEC) and the Directorate of Science and Technology (DoST). These projects, as both Principal and Co-Principal Investigator, reflect national recognition of his expertise and contributions. His continued involvement in funded research projects underscores his credibility and leadership in the scientific community. His honors not only represent personal achievements but also contribute to the growth of biotechnology research capacity in Pakistan. He remains committed to advancing microbiological science through innovation and collaboration.

Research Focus 

Dr. Sadiq Azam’s research centers on bacteriological profiling, molecular genetics of antibiotic resistance, and the pharmacological evaluation of medicinal plants. His primary focus is the identification of resistance genes in clinical isolates, including extended-spectrum β-lactamase (ESBL) and carbapenemase-producing Escherichia coli and Klebsiella pneumoniae. He employs molecular characterization techniques such as PCR, MIC testing, analytical profiling, and in-silico drug design to combat emerging bacterial threats. A parallel area of interest lies in the bioassay screening and phytochemical analysis of traditional medicinal plants like Silene conoidea, Sarcococca saligna, and Pinus wallichiana, aiming to discover novel antimicrobial compounds. His integrated approach bridges clinical microbiology with natural product chemistry, addressing global challenges in antibiotic resistance and infectious disease management. Through research supervision and project leadership, he actively contributes to building Pakistan’s research capacity in biotechnology, while aligning with global health priorities on antimicrobial stewardship and sustainable therapeutics.

Publication Top Notes

Title: Design and Validation of a Polyunit Epitope Vaccine Against Enterococcus faecium
Journal: Journal of Computational Biophysics and Chemistry
Summary:
This study likely focuses on the computational design and validation of a multi-epitope subunit vaccine targeting E. faecium, a notorious multidrug-resistant pathogen. The vaccine design may have used immunoinformatics tools to identify epitopes and predict immunogenicity.

Title: Towards Precision Epitopes Based Vaccine Against Enterococcus faecalis by Integrating Vaccinomics, Reverse Vaccinology and Biophysics Approaches
Journal: Biochemistry and Biophysics Reports
Summary:
The paper integrates vaccinomics and reverse vaccinology to identify precision epitopes for a vaccine targeting E. faecalis. It likely combines computational prediction, immunological profiling, and structural biophysics to develop a targeted vaccine strategy.

Title: Current Pattern of Antibiotic Resistance and Molecular Characterization of Virulence Genes in Klebsiella pneumoniae Obtained from Urinary Tract Infection (UTIs) Patients, Peshawar
Journal: PLOS ONE
Summary:
This research investigates antibiotic resistance patterns and the genetic basis of virulence in K. pneumoniae strains isolated from UTI patients in Peshawar. Likely includes PCR-based detection of virulence genes and antibiotic susceptibility profiling.

Title: Elucidating the Resistance Mechanisms and Binding Pattern of Novel Oxa-48-like Carbapenemases Covalent Inhibitors: A Hybrid Experimental and In Silico Approach
Journal: Journal of Molecular Structure
Summary:
The article explores how novel covalent inhibitors interact with Oxa-48-like carbapenemases—enzymes that confer resistance to carbapenem antibiotics. Uses both computational modeling and experimental data to understand resistance and inhibitor design.

Title: Green Synthesis and Characterisation of Desmodium podocarpum-Mediated Silver Nanoparticles and Their Biological Activities
Journal: Natural Product Research
Summary:
Focuses on the eco-friendly synthesis of silver nanoparticles using Desmodium podocarpum plant extract. Likely includes characterization (UV-Vis, SEM, FTIR) and evaluation of antimicrobial or antioxidant properties.

Conclusion 

Dr. Sadiq Azam stands as a leading academic and researcher in Pakistan’s biotechnology and microbiology landscape. His multidisciplinary expertise combines molecular microbiology, antimicrobial resistance research, and natural product pharmacology. With a strong academic foundation and over a decade of professional experience, he has contributed significantly to both science and education through impactful research, project leadership, and student mentorship. His work aligns with urgent global health issues such as drug-resistant infections and the search for alternative therapies. He has successfully led nationally funded projects and fostered collaborations across institutions. As an educator, Dr. Azam is deeply engaged in curriculum design, teaching innovation, and research supervision, shaping the next generation of scientists. His fluency in English, Urdu, and Pashto enables effective communication and outreach across diverse academic and community settings. Dr. Azam exemplifies the role of a dedicated researcher and educator committed to scientific advancement, public health improvement, and academic excellence in Pakistan.

Ragala Venkata Nandha | Clinical Microbiology | Best Scholar Award

Published on by Global Diseases Research

Mr. Ragala Venkata Nandha | Clinical Microbiology | Best Scholar Award 

Research Scholar at University of Madras, India

Ragala Venkata Nandha is a passionate young researcher currently pursuing his PhD in Medical Microbiology at Dr. ALM PG Institute of Basic Medical Sciences, University of Madras, Chennai. With a strong foundation in microbiological sciences, his work centers on antimicrobial resistance and advanced diagnostic techniques. He holds a Master’s degree in Medical Microbiology and a Bachelor’s in Medical Laboratory Technology. Nandha has contributed to multiple research projects funded by CMRG and RUSA 2.0, addressing clinical microbiology and drug resistance mechanisms. His scientific publications and conference presentations underscore his active engagement in cutting-edge research. As a first and co-author, he has contributed to reputed international journals and book chapters. He is a contributing member of the American Society for Microbiology and actively participates in conferences and workshops. Known for his practical expertise in molecular biology and microbial diagnostics, Nandha is committed to advancing solutions for combating infectious diseases and public health threats.

Professional Profiles

Scopus

Education

Ragala Venkata Nandha is academically trained in the field of microbiology and medical laboratory technology. He is currently enrolled in a PhD program in Medical Microbiology at the Department of Microbiology, Dr. ALM PG IBMS, University of Madras, where he is investigating antimicrobial resistance mechanisms. Prior to his doctoral studies, he earned his Master of Science (M.Sc.) in Medical Microbiology from the same institute, where he conducted research on probiotic enhancement. His undergraduate studies were in Medical Laboratory Technology (B.Sc. MLT) at Dr. NTR University, Vijayawada, Andhra Pradesh. Throughout his academic journey, Nandha has consistently focused on clinical microbiology, diagnostics, and molecular biology. His education has provided him with solid theoretical grounding and extensive hands-on laboratory experience in handling clinical specimens, performing molecular diagnostics, and applying modern research methodologies to real-world medical problems. His academic foundation supports his current research in combating multidrug-resistant pathogens.

Experience

Ragala Venkata Nandha has gained practical and research experience through his roles as a Project Fellow in two major funded research projects. He is currently working as a CMRG Project Fellow in the Department of Genetics at Dr. ALM PG IBMS, University of Madras, where he is developing a multiplex LAMP assay for rapid detection of resistance genes in colistin-resistant Enterobacteriaceae. Prior to this, he served as a RUSA 2.0 Project Fellow, focusing on the neuroimmunoendocrine effects of natural resources in neurodegenerative diseases. His experience includes microbial culture, molecular techniques such as PCR and sequencing, antimicrobial susceptibility testing, and analysis of co-resistance patterns. He also has hands-on training in animal handling and diagnostic laboratory workflows. These roles have enhanced his understanding of translational research and enabled him to contribute significantly to microbiology and infectious disease research at the institutional and national levels.

Research Focus 

Ragala Venkata Nandha’s research is centered on antimicrobial resistance (AMR) and molecular diagnostics. His current PhD project involves the isolation and molecular profiling of carbapenem- and colistin-resistant Gram-negative bacteria from clinical samples. The research aims to understand co-resistance patterns and the evolutionary mechanisms underlying these pathogens. In the CMRG project, he is developing a multiplex LAMP assay to detect mcr-1 to mcr-9 genes responsible for colistin resistance. His postgraduate work explored the prebiotic potential of spinach on probiotic growth, contributing to the understanding of gut microbiota modulation. He has also studied nanotechnology-based antimicrobial agents like eco-friendly silver nanoparticles. His work integrates microbiology, molecular biology, and bioinformatics to address critical healthcare challenges. With expertise in techniques like real-time PCR, Sanger sequencing, and bioinformatics analysis, his goal is to innovate diagnostics and therapeutic strategies for combating drug-resistant infections and improving clinical outcomes.

Publication Top Notes

Title: Advancing beyond conventional vaccines: The potential of next-generation vaccines in combatting antibiotic-resistant bacteria

Journal: Indian Journal of Medical Microbiology

Summary

This article explores the emerging landscape of next-generation vaccines designed to address the growing threat of antibiotic-resistant bacteria. Unlike traditional vaccines, which primarily rely on attenuated or inactivated pathogens, next-gen vaccines leverage novel platforms such as mRNA, recombinant proteins, vector-based systems, and nanoparticle technologies. The paper highlights how these vaccines offer greater specificity, faster development timelines, and adaptability against evolving bacterial strains. It also examines clinical trials, current research trends, and regulatory challenges, emphasizing the crucial role these vaccines play in reducing reliance on antibiotics and slowing antimicrobial resistance (AMR) worldwide.

Conclusion

Ragala Venkata Nandha represents a new generation of focused, skilled, and research-driven microbiologists working at the intersection of clinical diagnostics and antimicrobial resistance. His academic foundation, complemented by ongoing doctoral research, showcases a strong commitment to scientific inquiry and innovation. From molecular biology and nanotechnology to clinical microbiology and bioinformatics, his multidisciplinary approach addresses urgent public health concerns. His contributions as a project fellow, author, and conference presenter reflect both technical expertise and scientific maturity. As a member of international scientific communities and contributor to peer-reviewed literature, he continues to build a credible research profile. With promising achievements in diagnostics development and microbial resistance studies, Nandha is well-positioned to make a lasting impact in translational microbiological research. His journey reflects a dedication not only to academic excellence but also to solving real-world health challenges through research, collaboration, and innovation. He is a valuable asset to the scientific and medical research community.

Yuling Zou | Diabetic Retinopathy | Best Researcher Award

Published on by Global Diseases Research

Dr. Yuling Zou | Diabetic Retinopathy | Best Researcher Award 

Nanchang University ,China

Dr. Yuling Zou is an accomplished medical doctor and Associate Chief Physician at the Affiliated Eye Hospital of Jiangxi Medical College, Nanchang University. With a focus on ophthalmology, she also serves as a master’s supervisor and holds influential roles across several ophthalmic research institutions in Jiangxi Province. A PhD graduate from the Ophthalmology Center at Sun Yat-sen University, Dr. Zou has made notable contributions to the understanding and treatment of retinal diseases. She has led several research initiatives supported by national and provincial funding, published extensively in SCI-indexed journals, and developed multiple patented ophthalmic devices. Her expertise spans diabetic retinopathy, age-related macular degeneration, and ferroptosis mechanisms in retinal diseases. She actively mentors postgraduate students and contributes to academic development as an expert reviewer and editorial board member. Her leadership, innovation, and dedication to improving ocular healthcare have earned her recognition as a prominent figure in ophthalmology.

🔹 Professional Profile

🏆Strengths for the Award

Dr. Yuling Zou is a highly accomplished medical researcher in the field of ophthalmology, with a specialized focus on diabetic retinopathy and retinal disease mechanisms. Her strong academic foundation—built through a Ph.D. from the esteemed Sun Yat-sen University—and her extensive clinical and research experience have positioned her as a leader in translational vision science. As Associate Chief Physician and Master’s Supervisor at Nanchang University, she has led multiple nationally and provincially funded research projects and published over ten SCI-indexed articles. Notably, her work on ferroptosis and berberine-based therapies has opened promising avenues in treating retinal vascular disorders. Her six patents in ophthalmic surgical innovations further highlight her drive for practical clinical impact. Dr. Zou’s commitment to mentoring young researchers, active participation in editorial boards, and rigorous peer review contributions exemplify her holistic contribution to academic and scientific progress. These attributes make her a deserving nominee for the Best Researcher Award.

🎓 Education

Dr. Yuling Zou completed her doctoral studies at the prestigious Ophthalmology Center of Sun Yat-sen University, specializing in retinal disorders and ocular pathology. Her academic training provided a strong foundation in both clinical ophthalmology and advanced biomedical research. She gained further expertise in translational medicine and molecular mechanisms through hands-on research in diabetic retinopathy and retinal ferroptosis. Her education emphasized an integrated approach to clinical problem-solving, encouraging her to pursue innovation through rigorous academic inquiry. In addition to her PhD, she has undergone continuous professional development through conferences, specialized training, and academic collaborations. Dr. Zou’s academic journey reflects a commitment to excellence and a deep-rooted interest in improving patient care through evidence-based research. Her interdisciplinary background has allowed her to bridge the gap between laboratory findings and clinical applications, paving the way for novel treatments in ocular diseases. She continues to inspire future clinicians and researchers as an academic mentor and educator.

💼 Experience

With years of clinical and research experience, Dr. Yuling Zou currently serves as Associate Chief Physician at the Affiliated Eye Hospital of Jiangxi Medical College, Nanchang University. She supervises postgraduate students and is actively involved in both clinical ophthalmology and basic research. Dr. Zou has led and completed multiple high-impact research projects, including one funded by the National Natural Science Foundation of China and five provincially supported grants. She has authored over 10 SCI-indexed articles and holds six patents for ophthalmic surgical tools and innovations. Her work spans diabetic retinopathy, retinal neovascularization, and ferroptosis mechanisms. As an active member of professional bodies and a reviewer for national grants and international journals, she plays a key role in academic and clinical peer review. Her combined clinical acumen, research productivity, and leadership in ophthalmology position her as a valuable contributor to the advancement of vision science and patient care in China.

🔬 Research Focus on Diabetic Retinopathy

Dr. Yuling Zou’s research is centered on retinal diseases, particularly diabetic retinopathy and age-related macular degeneration. Her primary scientific focus lies in understanding ferroptosis mechanisms in retinal vascular endothelial cells and how these contribute to vision-threatening conditions. She has explored the pharmacological effects of berberine as a therapeutic agent to inhibit oxidative stress and cell death in diabetic retinal complications. Her translational research bridges basic molecular insights with clinical ophthalmic applications, aiming to discover novel targets for intervention. Dr. Zou has led multiple government-funded research projects, resulting in impactful findings published in leading journals such as Experimental Eye Research. Additionally, her work on ocular neovascularization has contributed to the development of more effective treatment strategies for degenerative eye diseases. Through her investigations, she continues to advance the field of ophthalmology by offering innovative solutions to complex retinal pathologies and mentoring emerging researchers to carry forward this important scientific work.

📚 Publications Top Notes

Intraocular fluid analysis-guided precision therapy in the treatment of acute retinal necrosis syndrome

Authors: [Not fully listed – typically includes multiple contributors. Based on your format, there are at least four authors, with ellipses indicating more.]

Journal: Scientific Reports, 2025
Citations: 63

Summary:
This study presents a novel approach using intraocular fluid analysis to guide precision therapy for acute retinal necrosis syndrome (ARN)—a rare but vision-threatening inflammatory condition. By tailoring treatment based on the molecular and immunological characteristics found in ocular fluid samples, the research suggests improved outcomes in inflammation control, viral suppression, and vision preservation compared to conventional, generalized therapy.

📌 Conclusion

Dr. Yuling Zou exemplifies the qualities of a distinguished medical researcher and clinician through her unwavering commitment to advancing ophthalmic science and improving patient outcomes. Her academic rigor, clinical insight, and innovative approach to solving retinal health challenges have positioned her as a leader in the field. From pioneering berberine-based retinal therapies to developing patented surgical tools, Dr. Zou’s contributions have tangible impacts on both research and clinical practice. She has mentored the next generation of ophthalmologists while maintaining active roles in editorial and review committees, reinforcing her influence in the scientific community. Her accolades, leadership positions, and ongoing research reflect a career dedicated to excellence and service. Dr. Zou’s body of work not only enriches the field of ophthalmology but also embodies the spirit of progress and integrity that defines a deserving candidate for the Best Researcher Award. Her continued efforts promise further advancements in ocular healthcare and biomedical science.

 

Yonghao Gui | Pediatrics | Best Researcher Award

Published on by Global Diseases Research

Prof. Dr. Yonghao Gui | Pediatrics | Best Researcher Award 

Professor at Children’s Hospital of Fudan University ,China

Dr. Yonghao Gui is a renowned Chinese pediatrician and academic leader in pediatric cardiology and child health. Born in Shanghai in 1958, he has devoted his career to advancing children’s healthcare through clinical practice, academic research, and institutional leadership. A graduate of Shanghai Medical University, Dr. Gui rose through clinical and academic ranks to become President of the Children’s Hospital at Fudan University and later Vice President and Executive Vice President of Fudan University. He has played a central role in developing China’s pediatric research infrastructure, with a special focus on congenital heart disease and neonatal health. As a leading figure in pediatrics, he has served as chairman of the Chinese Pediatric Association and chief editor of top pediatric journals. Widely published and respected, Dr. Gui has also represented China in global medical exchanges and training programs in the U.S., Japan, Germany, and Canada, contributing to international collaboration in pediatric care.

🔹Professional Profile 

🏆Strengths for the Award

Prof. Dr. Yonghao Gui is a pioneering figure in pediatric medicine with over four decades of impactful clinical, academic, and research contributions. As a global authority in pediatric cardiology, he has advanced the understanding of congenital heart disease through groundbreaking work on genetic and epigenetic regulation, maternal-fetal health, and miRNA pathways. His translational research, including antioxidant therapies and early-life interventions, bridges basic science with clinical care, positioning him at the forefront of precision pediatrics. Beyond research, Dr. Gui has demonstrated transformative leadership as President of the Children’s Hospital at Fudan University and Vice President of Fudan University, where he significantly enhanced pediatric research infrastructure in China. He has also influenced national child health policy, chaired key pediatric associations, and mentored generations of researchers. His prolific publications, editorial leadership, and international collaborations underscore his commitment to excellence, global knowledge exchange, and improving pediatric outcomes for children worldwide.

🎓 Education

Dr. Yonghao Gui began his medical education at Shanghai Medical University, where he earned his Bachelor of Science in Medicine from 1978 to 1982. During his early professional years, he pursued further academic enrichment in molecular biology through a continuing education program at the same institution. From 1991 to 1995, he was a visiting clinical research fellow at the Children’s Hospital of Philadelphia under the China/CHOP Academic Exchange Program, enhancing his expertise in pediatric cardiology. Later, from 1997 to 1999, he pursued a Master of Science degree in clinical epidemiology through the International Clinical Epidemiology Network (INCLEN) at its Southeast Asia Training Center in Bangkok. His commitment to lifelong learning also includes advanced hospital management courses at the University of British Columbia, Japan’s Osaka City University, and Germany’s Berlin Heart Institute. This rich educational background laid the foundation for his leadership in pediatric research and healthcare management in China.

💼Professional Experience 

Dr. Gui’s career spans over four decades of clinical, academic, and administrative excellence. He began as a resident at the Children’s Hospital of Shanghai Medical University and advanced to attending physician in pediatric cardiology. His international fellowship at the Children’s Hospital of Philadelphia enriched his clinical expertise. Upon return, he held leadership roles including Deputy Chief of Pediatrics and Cardiovascular Center. Rising steadily, he became Vice President, then President of the Children’s Hospital at Fudan University, and later served as Vice President and Executive Vice President of Fudan University. Dr. Gui directed the Research Institute at the Children’s Hospital and led national pediatric journals as editor-in-chief. He also chaired national pediatric associations and played a pivotal role in establishing the Neonatal Clinical Research Lab under the Ministry of Health. His professional trajectory reflects his dedication to child health, innovation in medical research, and excellence in institutional leadership within China’s top medical education systems.

🔬 Research Focus on Pediatrics

Dr. Yonghao Gui’s research primarily focuses on pediatric cardiology, especially the molecular and genetic underpinnings of congenital heart disease (CHD). As principal investigator on numerous national and municipal projects, he has explored early prevention, genetic regulation, microRNA roles, and epigenetic mechanisms in cardiac development. His work also delves into maternal-fetal interactions affecting neonatal cardiac health, including the impact of maternal diet, obesity, and metabolic disorders. Notably, his studies on gene-environment interactions and miRNA-mediated pathways offer insights into CHD pathogenesis. Dr. Gui has led multi-year projects funded by the National Natural Science Foundation and China’s “Double First-Class” initiative, focusing on early childhood health maintenance, cardiac enhancers, and transcription factor regulation. His translational research often utilizes zebrafish models and single-cell analysis to bridge clinical pediatrics and molecular science. Through these efforts, Dr. Gui is advancing precision medicine approaches for early detection, prevention, and intervention in pediatric cardiovascular diseases.

📚 Publications Top Notes

Antioxidant Management to Protect Male Offspring from the Progression of MASLD Programmed by Maternal Obesity in Mice

Authors: Jialing Zhang, Jiayu Wang, Da Xu, Fang Wu, Yonghao Gui
Journal: The Journal of Nutritional Biochemistry
Summary:
This study explores how antioxidant supplementation during pregnancy can mitigate the risk of metabolic dysfunction-associated steatotic liver disease (MASLD) in male offspring of obese mice. The findings suggest that antioxidant treatment may reduce oxidative stress and hepatic lipid accumulation, thereby protecting the liver health of offspring affected by maternal obesity.

Promoting Glutathione Synthesis: A Possibility for Treating Cardiomyopathy Induced by a Maternal Western Diet

Authors: Jialing Zhang, Jiayu Wang, Da Xu, Yiting Gui, Fan Bai, Yu Huo, Li Cao, Yonghao Gui
Journal: Nutrients
Summary:
The study investigates the therapeutic potential of enhancing glutathione synthesis to treat cardiomyopathy in offspring exposed to a maternal Western diet. Results indicate that boosting antioxidant defense through glutathione pathways can improve heart structure and function in these mice, suggesting a preventative strategy for diet-induced cardiovascular programming.

Protective Effect of Antioxidants on Cardiac Function in Adult Offspring Exposed to Prenatal Overnutrition

Authors: Jialing Zhang, Li Cao, Wenji Wang, Yu Huo, Yuanzheng Zheng, Fang Wu, Yonghao Gui
Journal: Journal of Developmental Origins of Health and Disease
Summary:
This article reports on how prenatal antioxidant therapy helps preserve cardiac function in adult mice born to mothers with high-calorie diets. The study emphasizes that early nutritional interventions can buffer the long-term adverse effects of maternal overnutrition on cardiovascular health in offspring.

📌 Conclusion

Dr. Yonghao Gui stands as a pillar in pediatric medicine, seamlessly integrating clinical excellence, academic leadership, and groundbreaking research. With decades of contributions to pediatric cardiology, he has significantly advanced our understanding of congenital heart disease and its early prevention. His leadership roles at Fudan University and national pediatric associations underscore his commitment to enhancing healthcare infrastructure and medical education in China. Through cross-disciplinary and international collaborations, Dr. Gui has nurtured innovation in child health research and policy. His editorial work and textbook authorship reflect a deep dedication to shaping the next generation of pediatric professionals. Whether pioneering molecular studies or directing top-tier hospitals and academic units, Dr. Gui embodies the ideals of a clinician-scientist committed to societal well-being. His sustained impact across research, teaching, and leadership continues to inspire medical professionals and improve child health outcomes nationally and globally. He remains a respected voice in both China’s and the world’s pediatric communities.

Amer Khan | Education and Adherence | Best Scholar Award

Published on by Global Diseases Research

Dr. Amer Khan | Education and Adherence | Best Scholar Award 

Senior Lecturer at Universiti Sains Malaysia ,Malaysia

Dr. Amer Hayat Khan is a dedicated academic and researcher in the field of Clinical Pharmacy. Serving as a Senior Lecturer at the School of Pharmaceutical Sciences, Universiti Sains Malaysia (USM), he brings over a decade of expertise in teaching, clinical practice, and pharmaceutical research. A native of Pakistan, Dr. Khan has established himself as a prominent figure in pharmacyhttps://globaldiseases.org/amer-khan-education-and-adherence-best-scholar-award-1607/ education and research across Asia. He is actively involved in supervising postgraduate research, conducting clinical trials, and contributing to numerous international collaborations. His strong academic background, paired with a commitment to public health and community service, reflects his holistic approach to healthcare advancement. With over 300 publications, a Scopus H-index of 26, and a significant cumulative impact factor, Dr. Khan continues to influence both policy and practice in pharmacy. He maintains a strong presence in global research platforms, further extending his reach and collaborative potential across the scientific community.

🔹 Professional Profile

🏆Strengths for the Award

1. Academic Excellence and Educational Leadership
Dr. Khan holds a Ph.D. in Clinical Pharmacy and has demonstrated exceptional academic performance throughout his career. He has contributed significantly to curriculum development, undergraduate and postgraduate teaching, and the design of experiential learning programs such as clerkships and OSPhE assessments. His pedagogical methods integrate real-world clinical insights, reinforcing evidence-based learning.

2. Pioneering Research on Adherence and Education
Dr. Khan’s research, particularly in medication adherence, infectious diseases, and clinical education models, addresses crucial healthcare challenges. His recent work on TB treatment adherence using the Health Belief Model exemplifies innovative, theory-driven educational interventions with clinical impact.

3. Mentorship and Capacity Building
With supervision of over 50 postgraduate theses, including 29 Ph.D. candidates, Dr. Khan has made major contributions to building future research leaders. His mentorship spans multiple continents, fostering global capacity in pharmacy research.

4. Global Research Collaborations
Dr. Khan’s collaborations with institutions in South Asia, the Middle East, and Australia highlight his international influence. His work aligns with cross-border healthcare priorities such as antimicrobial resistance and geriatric pharmacotherapy, making him a central figure in translational research.

5. Outstanding Publication Record
With 300+ publications, a Scopus h-index of 26, and cumulative impact factor exceeding 426, his output reflects both quality and consistency. His articles are widely cited, spanning high-impact journals and addressing both regional and global public health needs.

6. Community and Public Health Engagement
Dr. Khan’s involvement in awareness campaigns, patient education initiatives, and antibiotic stewardship programs underlines his commitment to public service. His work bridges academic insight with real-world implementation, a rare and valuable quality in modern scholarship.

🎓 Education

Dr. Amer Hayat Khan pursued his higher education with a clear focus on pharmacy. He obtained his Ph.D. in Clinical Pharmacy from Universiti Sains Malaysia (USM), where he later joined the academic faculty. Prior to that, he completed his M.Phil and Bachelor of Pharmacy degrees at Gomal University in Pakistan. His academic training laid a strong foundation in both pharmaceutical sciences and clinical pharmacy practice, equipping him with in-depth knowledge essential for advanced teaching and research. To complement his formal education, Dr. Khan earned certifications in Good Clinical Practices (GCP) from the Ministry of Health, Malaysia. These qualifications have allowed him to operate effectively in both academic and clinical environments, emphasizing evidence-based approaches in pharmacy education and research. His diverse educational background supports his multifaceted roles as a teacher, researcher, and mentor in the field of clinical pharmacy at the international level.

💼 Experience

Dr. Amer Hayat Khan has over a decade of academic and clinical experience in pharmacy. Since October 2011, he has served as a Senior Lecturer at the School of Pharmaceutical Sciences, Universiti Sains Malaysia (USM). His responsibilities include teaching undergraduate and postgraduate pharmacy courses, supervising thesis research, and conducting structured hospital visits for pharmacy clerkship. Dr. Khan also plays a pivotal role in training students through Objective Structured Pharmacy Examinations (OSPhE), problem-solving sessions, and community health initiatives. As a Clinical Pharmacy Specialist, he integrates research with teaching and service delivery, enhancing pharmaceutical care training. He has also supervised over 50 postgraduate research projects, contributing extensively to capacity-building in pharmacy education. His experience spans across national borders, involving active collaborations with research institutions in the Middle East, South Asia, and Australia. His career reflects a commitment to advancing pharmacy practice through education, innovation, and international research partnerships.

🏆Awards and Honors

Dr. Amer Hayat Khan has been the recipient of numerous awards and competitive research grants throughout his academic career. These accolades recognize his outstanding contributions to clinical pharmacy education, research, and service. He is actively engaged in academic peer-review processes, serving as a reviewer for prestigious journals and as an examiner for postgraduate theses at various universities. His extensive research portfolio, supported by international and institutional grants, has earned him recognition within and beyond Malaysia. He has played a key role in advancing pharmaceutical sciences, particularly through impactful studies on infectious diseases, antibiotic stewardship, and adherence issues. With a cumulative article impact factor of over 426.50 and an abstract impact factor exceeding 144.44, his scientific output has made a significant contribution to global pharmacy research. His achievements are not only academic but also reflect his dedication to public health and community engagement, solidifying his position as a leader in the field.

🔬 Research Focus on Education and Adherence

Dr. Amer Hayat Khan’s research interests center around Clinical Pharmacy with a strong focus on Infectious Diseases, Antibiotic Stewardship, Geriatric Issues, Adherence Challenges, and Epidemiology. His work aims to bridge the gap between clinical practice and academic research by addressing real-world pharmaceutical challenges. He has supervised 29 Ph.D. and numerous master’s research projects, often involving clinical trials, observational studies, and pharmacological interventions. His research frequently explores medication adherence in elderly populations and the optimization of antibiotic use to combat resistance. Through international collaborations with institutions across Saudi Arabia, India, Pakistan, UAE, and Australia, he has contributed to a global understanding of pharmacy practices. Dr. Khan’s publications are widely cited, and his projects often emphasize evidence-based practices that can inform healthcare policy and improve clinical outcomes. His research agenda reflects a commitment to improving patient care and enhancing pharmaceutical education through innovative, interdisciplinary approaches.

📚 Publications Top Notes

Pharmacist-led Education Intervention to Improve Pulmonary Tuberculosis Treatment Adherence Through the Health Belief Model in Malaysia: A Study Protocol for a Randomized Trial

Authors: R Ahmad, SMS Ghadzi, IABH Ali, SAS Sulaiman, AH Khan
Journal: Monaldi Archives for Chest Disease, 2025
Summary: This study outlines a randomized controlled trial (RCT) protocol investigating the effectiveness of a pharmacist-led intervention based on the Health Belief Model (HBM) to improve treatment adherence among pulmonary TB patients in Malaysia. The intervention aims to address patient beliefs, perceived severity, susceptibility, and barriers to adherence, using structured educational sessions.

Risk Factors of Acute Kidney Injury Patients Presenting to Tertiary Care Hospital

Authors: A Khan, W Khan, A Jabbar, M Khan, Z Ullah
Journal: Pakistan Journal of Intensive Care Medicine, Vol. 5(01), Page 92, 2025
Summary: This cross-sectional study identifies clinical and demographic risk factors associated with Acute Kidney Injury (AKI) among patients in a tertiary care setting in Pakistan. Major findings point to the role of comorbidities such as diabetes, hypertension, and sepsis as leading contributors.

Evaluation of Social and Clinical Factors Associated with Adverse Drug Reactions Among Children with Drug-Resistant Tuberculosis in Pakistan

Authors: MS Said, R Fatima, R Ahmad, MBA Al Rawi, F Jan, S Faisal, I Khan, AH Khan, et al.
Journal: Tropical Medicine and Infectious Disease, 10(7), Article 176, 2025
Summary: This research examines the correlation between social determinants (like caregiver education) and clinical features (polypharmacy, nutritional status) in the incidence of adverse drug reactions in pediatric DR-TB patients. It advocates for improved monitoring and targeted risk assessments.

Impact of COVID-19 on Clinical Characteristics in Type 2 Diabetes Patients: A Prospective, Longitudinal, Observational Study

Authors: T Azim, AH Khan, F Sadiq, SAS Sulaiman, DAM Noor, U Wahab, O Ishtiaq
Journal: Diabetes Research and Clinical Practice, Article 112316, 2025
Summary: This study explores how COVID-19 altered clinical outcomes and glycemic control in T2DM patients over time. Results reveal significant metabolic derangements, increased insulin requirements, and higher hospitalization rates during infection periods.

Systematic Review and Meta-analysis Protocol of Impact of Pharmacist-Led Antibiotic Stewardship Audit-Feedback Intervention

Authors: DS Jawhar, AH Khan, K Alam
Journal: MethodsX, Article 103399, 2025
Summary: The paper proposes a protocol for a systematic review and meta-analysis aimed at evaluating the effectiveness of pharmacist-led audit-feedback interventions on antibiotic prescribing practices. It adheres to PRISMA-P standards and seeks to inform global antimicrobial stewardship policies.

Prevalence of Cardiovascular Disease Among Tuberculosis Patients in Penang General Hospital, Malaysia

Authors: B Kingrani, AH Khan, SN Harun, FAS Khiery, IAH Ali, A Qureshi
Journal: [Details not specified], 2025
Summary: This epidemiological study assesses the coexistence of cardiovascular disease (CVD) among TB patients, highlighting a high prevalence and stressing the need for integrated CVD screening in TB care programs.

Cardiovascular Mortality Among Tuberculosis Patients

Authors: B Kingrani, AH Khan, SN Harun, A Qureshi, IAH Ali, MB Al-Rawi, I Khan
Journal: [Details not specified], 2025
Summary: The study reports an increased rate of cardiovascular-related deaths in TB patients, suggesting that TB-induced systemic inflammation might accelerate cardiovascular risks. Calls for enhanced cardiovascular monitoring are made.

Exploring Antibiotic Resistance Patterns in Escherichia coli Isolates from Urinary Tract Infections: A Retrospective Study

Authors: R Alkhawaldeh, L Gharaibeh, AH Khan, K Abu Hammour, M Zawiah, et al.
Journal: Journal of Clinical Medicine, 14(9), Article 3196, 2025
Summary: Retrospective data analysis reveals increasing antibiotic resistance in E. coli isolates, especially to fluoroquinolones and beta-lactams. The paper recommends urgent antimicrobial stewardship and rational prescription practices.

Parental Awareness and Practices of Self-Medication with Antibiotics Among Hospitalized Children: Findings and Implications from a Cross-Sectional Study

Authors: ZU Mustafa, AH Khan, M Salman, SN Harun, J Meyer, B Godman
Journal: Advances in Human Biology, 2025
Summary: This cross-sectional study identifies significant gaps in parental understanding of antibiotic use in pediatric patients. The study emphasizes the role of public health education in combating antibiotic misuse.

Baseline Predictors of Antibiotics De-escalation from Empirical Therapies in an Intensive Care Unit: A Five-Year Retrospective Study

Authors: AL Arulappen, AH Khan, M Danial, SS Hasan, TS Chow, NJ Ahmed, et al.
Journal: BMC Infectious Diseases, 25(1), Article 369, 2025
Summary: Over a 5-year period, the study identifies clinical predictors (e.g., culture sensitivity results, clinical stability) that influenced successful antibiotic de-escalation in ICU patients. The study supports promoting de-escalation to reduce resistance.

📌 Conclusion

Dr. Amer Hayat Khan exemplifies a balanced academic professional with strengths in teaching, research, and clinical practice. His extensive educational background, coupled with over a decade of academic service at Universiti Sains Malaysia, underlines his dedication to advancing the field of Clinical Pharmacy. As a mentor, he has significantly contributed to postgraduate education and research supervision, while his global research collaborations highlight his international impact. Dr. Khan’s work in infectious diseases, antibiotic stewardship, and elderly care aligns with current healthcare priorities, reflecting his forward-thinking approach. His recognition through awards, grants, and high-impact publications attests to the quality and relevance of his contributions. Committed to community health and evidence-based practice, he continues to influence the next generation of pharmacists and healthcare professionals. His career trajectory positions him not only as an academic leader but also as a valuable contributor to global public health and clinical pharmacy advancement.